MDSteps Library Preview
You’ve viewed 0 of 5 free topics. Full QBank + CCS + Library is $27/month.
Continue for $27/mo
MDSteps- USMLE® Reference Library

Chronic Spontaneous Urticaria — Stepwise Therapy

System: Immunology • Reviewed: Aug 31, 2025 • Step 1Step 2Step 3

Synopsis:

Begin with daily non sedating H1 antihistamine, increase dose stepwise, add omalizumab for refractory disease, and consider cyclosporine under specialist care.

Key Points

  • Stabilize ABCs; begin targeted evaluation without delaying life-saving therapy.
  • Use system-specific risk tools to guide testing and disposition.
  • Order high-yield tests first; escalate imaging when indicated.
  • Start evidence-based initial therapy and reassess frequently.

Algorithm

  1. Primary survey and vitals; IV access and monitors.
  2. Focused history/physical; identify red flags and likely etiologies.
  3. Order system-appropriate labs and imaging (see Investigations).
  4. Initiate guideline-based empiric therapy (see Pharmacology).
  5. Reassess response; arrange consultation and definitive management.

Clinical Synopsis & Reasoning

For Chronic Spontaneous Urticaria First Line, frame the differential by acuity and pathophysiology, then align diagnostics to the leading hypotheses. Prioritize stabilization while obtaining high‑yield studies such as CBC (Baseline hematology), BMP (Electrolytes/renal). Incorporate bedside imaging and targeted labs to define severity and identify complications; synthesize results with clinical trajectory to refine the working diagnosis and disposition needs.


Treatment Strategy & Disposition

Initiate disease‑directed therapy alongside supportive care, titrating to objective response. Pharmacologic options commonly include Analgesia/Antipyretics. Use validated frameworks (e.g., Therapy Ladder) to guide escalation and site of care. Address precipitating factors, de‑escalate empiric therapies with data, and arrange follow‑up for monitoring and risk‑factor modification; admit patients with instability, high risk of deterioration, or needs for close monitoring.


Epidemiology / Risk Factors

  • Risk factors vary by condition and patient profile

Investigations

TestRole / RationaleTypical FindingsNotes
CBCBaseline hematologyAbnormal counts
BMPElectrolytes/renalDerangements

Therapy Ladder

StepIntervention
1Daily non sedating H1 antihistamine
2Increase dose stepwise
3Omalizumab
4Cyclosporine with monitoring

Pharmacology

MedicationMechanismOnsetRole in TherapyLimitations
CetirizineH1 antagonismHoursSymptomatic reliefSedation (less)
Epinephrine (if airway compromise)α/β agonistMinutesAnaphylaxis overlapArrhythmia

Prognosis / Complications

  • Prognosis depends on severity, comorbidities, and timeliness of care

Patient Education / Counseling

  • Explain red flags and when to seek emergent care.
  • Reinforce medication adherence and follow-up plan.

Notes

Avoid sedating antihistamines when driving or operating machinery. Address quality of life and sleep disturbance.


References

  1. EAACI CSU Guideline — Link
  2. AAAAI Practice Parameters — Urticaria — Link
MDSteps USMLE Prep

Use the Library, QBank, CCS, and analytics in one study workflow.

You just reviewed Chronic Spontaneous Urticaria — Stepwise Therapy. MDSteps helps you turn that review into exam-style practice, missed-item flashcards, and a readiness dashboard that shows what to study next.

  • 16,000+ USMLE-style questions across Step 1, Step 2, and Step 3
  • CCS simulator with timed orders, live vitals, and case feedback
  • Depth-on-Demand™ explanations and Anki-exportable flashcards
  • Library + QBank + analytics for $27/month or $299 lifetime

You’ve reached your MDSteps Library preview limit

Continue with full MDSteps access: Library, adaptive QBank, CCS simulator, and readiness analytics for $27/month or $299 lifetime.

  • Full access to all reference topics
  • 16,000+ USMLE-style questions with teaching-grade rationales
  • Realistic CCS cases with live vitals
  • Exam readiness dashboard & study insights